The pressure to outsource communications services presents an excellent opportunity for providers of medical communications programs to the European pharmaceutical industry. These companies undergo intense pressure to develop rich drug pipelines and therefore typically subcontract communications programs to a large extent. They can afford to finance and expect world-class communications programs. These are typically nationally-based, have a limited number of affiliates, and market their product to a limited number of countries. These companies do not have the internal competencies to implement high-performance, innovative communications programs and therefore have to fully subcontract these services.
Cost is therefore an important factor in the purchasing decision.
The services are global by essence, and therefore our offer will reflect the image of this global approach. Boomerang Table of Contents Appendices 1. All information herein is confidential and proprietary to Boomerang.